Abstract
Aims and objectivesIn this present study we have evaluated the feasibility of sub-classification of non-Hodgkin's lymphoma (NHL) cases according to World Health Organization's (WHO) classification on fine needle aspiration cytology (FNAC) material along with flow cytometric immunotyping (FCI) as an adjunct.Materials and methodsIn this five years study, only cases suggested or confirmed as NHL by FNAC were selected and FCI was performed with a complete panel of antibodies (CD3, CD2, CD 4, CD5, CD8, CD7, CD10, CD19, CD20, CD23, CD45, κ and λ) by dual color flow cytometry. Both cytologic findings and FCI data were interpreted together to diagnose and sub-classify NHL according to WHO classification. Wherever possible the diagnoses were compared with cytology.ResultsThere were total 48 cases included in this study. The cases were classified on FNAC as predominant small cells (12), mixed small and large cells (5) and large cells (26). In five cases a suggestion of NHL was offered on FNAC material and these cases were labeled as NHL not otherwise specified (NHL-NOS). Flow cytometry could be performed in 45 cases (93.8%) and in rest of the three cases the material was inadequate because of scanty blood mixed aspirate. Light chain restriction was demonstrated in 30 cases out of 40 cases of B-NHL (75%). There were 15 cases each of κ and λ light chain restriction in these 30 cases. With the help of combined FCI and FNAC, it was possible to sub-classify 38 cases of NHL (79%) according to WHO classification. Combined FNAC and FCI data helped to diagnose 9 cases of small lymphocytic lymphoma (SLL), 2 cases of mantle cell lymphoma (MCL), 4 cases of follicular lymphoma (FL), 17 cases of diffuse large B lymphoma (DLBL) and 6 cases of lymphoblastic lymphoma. Histopathology diagnosis was available in 31 cases of NHL out of which there were 14 recurrent and 17 cases of primary NHL. Out of 15 DLBL cases diagnosed on FCI and FNAC, histology confirmed 14 cases and one of these cases was diagnosed as Burkitt's lymphoma on histology. Cases of FL (4), SLL (3) and MCL (2) were well correlated with histopathology. Out of the five cases suggestive of NHL on cytology, histopathology was available in four cases. Histology diagnosis was given as DLBL (1), SLL (1), anaplastic large cell lymphoma (1) and FL transformed into large cell NHL (1). Considering histopathology as gold standard, diagnostic specificity of combined FNAC and FCI was 100% (31/31) and sensitivity in sub-classification was 83.8% (26/31).ConclusionFNAC combined with FCI may be helpful in accurately sub-classifying NHL according to WHO classification. Many of the subtypes of NHL such as FL and MCL which were previously recognized as a pure morphologic entity can be diagnosed by combined use of FNAC and FCI. Other ancillary investigations such as chromosomal changes, cell proliferation markers etc. may be helpful in this aspect.
Highlights
Fine needle aspiration cytology (FNAC) is a very helpful technique in diagnosis of benign and malignant lesions of lymph node [1,2,3,4]
Out of 15 diffuse large B lymphoma (DLBL) cases diagnosed on flow cytometric immunotyping (FCI) and FNAC, histology confirmed 14 cases and one of these cases was diagnosed as Burkitt's lymphoma on histology
Histology diagnosis was given as DLBL (1), small lymphocytic lymphoma (SLL) (1), anaplastic large cell lymphoma (1) and follicular lymphoma (FL) transformed into large cell non-Hodgkin's lymphoma (NHL) (1)
Summary
Fine needle aspiration cytology (FNAC) is a very helpful technique in diagnosis of benign and malignant lesions of lymph node [1,2,3,4]. Many authors claim that FNAC can accurately diagnose Hodgkin's and non-Hodgkin's lymphoma (NHL)[5,6]. The role of cytology in primary diagnosis and sub-classification of non-Hodgkin's lymphoma is controversial [9,10,11,12]. WHO and REAL classification emphasized immense importance on the cytomorphology and immunophenotype of lymphoma for accurate sub classification [13,14]. In this present study we have analyzed the role of flow cytometric immunotyping as an adjunct to FNAC for diagnosis and sub-classification of NHL according to WHO classification
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.